WallStSmart
EVO

Evotec SE ADR

NASDAQ: EVO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$1.32
-8.97% today

Updated 2026-11-20

Market cap
$600.61M
P/E ratio
—
P/S ratio
0.84x
EPS (TTM)
$-0.59
Dividend yield
—
52W range
$1 – $4
Volume
0.1M

Evotec SE ADR (EVO) Financial Forecast & Price Target 2030

Revenue-driven projection model with historical context.

Price target summary

Current price
$1.32
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$33.26

Financial forecast

Metric202120222023202420252027 (E)2028 (E)2029 (E)2030 (E)
Revenue$0.6B$0.8B$0.8B$0.8B$0.8B$0.8B$0.9B$1.0B$1.1B
EPS—————————
CAGR applied: 8.62% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -25.20%

Methodology

CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.